RESUMO
OBJECTIVE: The aim was to study the association between use of antidepressant medication and suicidal ideation in different diagnostic groups in a large population-based cohort. METHODS: Information on prescribed drugs within the Northern Finland Birth Cohort 1966 was collected at the age of 31 years with postal questionnaire (N= 8218). The presence of suicidal ideation was assessed via the Hopkins Symptom Checklist-25 questionnaire. We studied associations between suicidal ideation and antidepressant medication in various diagnostic and symptom groups, and it adjusted for symptoms of depression and anxiety. RESULTS: Suicidal ideation was associated with the use of antidepressant medication in all diagnostic groups, but the association disappeared with adjustment for other symptoms of depression and anxiety. Subjects who reported insomnia and used antidepressants had suicidal ideation more commonly than did subjects who were not using antidepressants even when other symptoms were adjusted for (p = 0.02). There were no statistically significant differences between antidepressant groups or doses. CONCLUSION: In a large unselected cohort, antidepressant medication was not associated with increased suicidal ideation when other symptoms of depression and anxiety were taken into account. The assessment of insomnia might be useful for identifying individuals liable to have increased suicidal ideation while on antidepressant medication.
Assuntos
Antidepressivos/uso terapêutico , Ideação Suicida , Adulto , Ansiedade/epidemiologia , Estudos de Coortes , Depressão/epidemiologia , Feminino , Finlândia/epidemiologia , Humanos , Masculino , Índice de Gravidade de Doença , Distúrbios do Início e da Manutenção do Sono/epidemiologia , Inquéritos e QuestionáriosRESUMO
In addition to psychoses, antipsychotic drugs are nowadays also prescribed for other psychiatric disturbances, such as mood disorders. We wanted to find out whether there is any association between the use of antipsychotic drugs and suicidality in cases of psychotic and non-psychotic disorders. Our sample was the population-based Northern Finland 1966 Birth Cohort. Information on the use of prescribed drugs was collected in 1997 from the nationwide medication register and with a postal questionnaire (N = 8218). The presence of suicidal ideation was assessed cross-sectionally using the Symptom Check List-25 questionnaire. We studied associations between suicidal ideation, adjusted for symptoms of depression and anxiety, and antipsychotic medication in different diagnostic groups (schizophrenia, other psychosis and no psychosis). Individuals receiving antipsychotic medication (n = 70, 0.9%) had in general more suicidal ideation regardless of diagnostic group, although the associations diminished when taking other symptoms into account. There were no statistically significant differences between those taking typical and atypical antipsychotics. In the non-psychotic group, higher antipsychotic doses were associated with more suicidal ideation even when adjusted for symptoms of depression and anxiety (p < 0.05). In the cases of schizophrenia or other forms of psychosis, no such associations were observed. Our results suggest that one should take suicidal ideation into account when prescribing antipsychotic medication, especially for off-label use.
Assuntos
Antipsicóticos/efeitos adversos , Ideação Suicida , Tentativa de Suicídio/estatística & dados numéricos , Suicídio/estatística & dados numéricos , Antipsicóticos/administração & dosagem , Antipsicóticos/uso terapêutico , Estudos Transversais , Relação Dose-Resposta a Droga , Feminino , Finlândia , Humanos , Masculino , Uso Off-Label , Estudos Prospectivos , Transtornos Psicóticos/tratamento farmacológico , Sistema de Registros , Esquizofrenia/tratamento farmacológico , Inquéritos e QuestionáriosRESUMO
PURPOSE: To investigate those ante- and perinatal circumstances preceding suicide attempts and suicides, which have so far not been studied intensively. METHODS: Examination of the Northern Finland Birth Cohort 1966 (n = 10,742), originally based on antenatal questionnaire data and now followed up from mid-pregnancy to age 39, to ascertain psychiatric disorders in the parents and offspring and suicides or attempted suicides in the offspring using nationwide registers. RESULTS: A total of 121 suicide attempts (57 males) and 69 suicides (56 males) had occurred. Previously unstudied antenatal factors (maternal depressed mood and smoking, unwanted pregnancy) were not related to these after adjustment. Psychiatric disorders in the parents and offspring were the risk factors in both genders. When adjusted for these, the statistically significant risk factors among males were a single-parent family for suicide attempts (OR 3.71, 95% CI 1.62-8.50) and grand multiparity for suicides (OR 2.67, 95% CI 1.15-6.18). When a psychiatric disorder in females was included among possible risk factors for suicide attempts, it alone remained significant (OR 15.55, 8.78-27.53). CONCLUSIONS: A single-parent family was a risk factor for attempted suicides and grand multiparity for suicides in male offspring even after adjusting for other ante- and perinatal circumstances and mental disorders in the parents and offspring. Mothers' antenatal depressed mood and smoking and unwanted pregnancy did not increase the risk of suicide, which is a novel finding.
Assuntos
Mães/psicologia , Tentativa de Suicídio/estatística & dados numéricos , Suicídio/estatística & dados numéricos , Adulto , Estudos de Coortes , Depressão/diagnóstico , Depressão/epidemiologia , Depressão/psicologia , Características da Família , Feminino , Finlândia/epidemiologia , Humanos , Modelos Logísticos , Masculino , Idade Materna , Transtornos Mentais/diagnóstico , Transtornos Mentais/epidemiologia , Transtornos Mentais/psicologia , Mães/estatística & dados numéricos , Razão de Chances , Paridade , Gravidez , Gravidez não Desejada/psicologia , Fatores de Risco , Pais Solteiros/psicologia , Pais Solteiros/estatística & dados numéricos , Fumar/epidemiologia , Fatores Socioeconômicos , Estresse Fisiológico , Suicídio/psicologia , Tentativa de Suicídio/psicologia , Inquéritos e Questionários , Adulto JovemRESUMO
Advanced paternal age is a risk factor for adverse health outcomes in the offspring. In a population-based birth cohort from Finland, 10,965 singleton offspring born in 1966 and alive at age 1 were followed to age 39. Hazard ratios were calculated, adjusting for maternal age, gender, paternal social class, and maternal parity. In females but not in males, increasing paternal age was associated with a linear increased risk of suicide (hazard ratio [HR] = 1.13, 95% confidence interval [CI] = 1.04-1.24, p < 0.01) and all-causes mortality (HR = 1.06, 95% CI = 1.01-1.10, p = 0.02). Increasing maternal age was associated with a significantly decreased risk of suicide (HR = 0.93, 95% CI = 0.86-1.00, p = 0.04) and all-causes mortality (HR = 0.96, 95% CI = 0.93-1, p = 0.02) in the entire cohort. For paternal age >/=30, the population attributable risk percentage was 13.7% for all deaths and 7.5% for suicides. Parental age at birth may affect suicide and all-causes mortality risk in the offspring in the general population. The causal pathways and specific disorders associated with this increased mortality are largely unknown.
Assuntos
Causas de Morte , Idade Paterna , Suicídio/estatística & dados numéricos , Adulto , Distribuição por Idade , Estudos de Coortes , Feminino , Finlândia/epidemiologia , Humanos , Estudos Longitudinais , Masculino , Idade Materna , Pessoa de Meia-Idade , Pais , Modelos de Riscos Proporcionais , Fatores de Risco , Fatores Sexuais , Classe SocialRESUMO
BACKGROUND: Suicide rate among schizophrenia patients may vary for several reasons, one of the most important being the time point of the suicide during the illness process. However, prospective studies on suicide risk in population-based cohort of individuals with new-onset schizophrenia have been lacking. METHOD: The data were collected for 10,934 individuals alive in Finland at the age of 16 from the genetically homogenous, population-based Northern Finland 1966 Birth Cohort ascertained already during mid-pregnancy. The Finnish Hospital Discharge Register was used until the end of 1997 (age 31) to identify cases with mental disorder. Case records were scrutinized and diagnoses were re-checked for DSM-III-R criteria. One hundred subjects met the DSM-III-R criteria for schizophrenia. Deaths by the end of year 2005 (age 39) were ascertained from death certificates. RESULTS: Suicides (n = 7) accounted for 50% of all the deaths at age from 16 to 39. Seven (7.0%) subjects with schizophrenia had committed suicide; suicide rate being 2.9% (1/35) for women and 9.2% (6/65) for men. Furthermore, 71% of suicides in schizophrenia occurred during the first 3 years after onset of illness. CONCLUSION: The suicide rate for patients with new-onset schizophrenia followed until the age of 39 was high and accounted for half of the deaths. Great majority of the suicides took place during the first years of the illness.
Assuntos
Esquizofrenia/mortalidade , Suicídio/estatística & dados numéricos , Adolescente , Adulto , Idade de Início , Causas de Morte , Estudos de Coortes , Feminino , Finlândia/epidemiologia , Seguimentos , Humanos , Masculino , Mortalidade , Prevalência , Estudos Prospectivos , Fatores de Risco , Esquizofrenia/diagnóstico , Esquizofrenia/epidemiologia , Psicologia do Esquizofrênico , Suicídio/psicologiaRESUMO
AIM: This study investigated how the level of school performance is associated with suicidal behavior and psychiatric disorders among adolescent psychiatric inpatients aged 12-17 years. METHODS: Data were collected from 508 adolescents (300 girls, 208 boys; age 12-17 years) admitted to inpatient psychiatric hospitalization between April 2001 and March 2006. Information on the adolescents' school performance, suicidal ideation, suicide attempts and self-mutilation as well as psychiatric DSM-IV diagnoses was obtained using the Schedule for Affective Disorder and Schizophrenia for School-Age Children. RESULTS: An elevated risk of suicidal ideation (OR = 3.6, 95% CI 1.3-10.2, P = 0.017) and of psychotic disorders (OR = 3.2, 95% CI 1.0-10.0, P = 0.048) was observed among male adolescents performing well in school. In addition, adolescents with poor school performance had an increased likelihood of substance-related disorder both in boys (OR = 2.6, 95% CI 1.1-6.1, P = 0.027) and girls (OR = 2.5, 95% CI 1.2-5.1, P = 0.011). CONCLUSIONS: Our findings indicate that psychotic inpatient male adolescents performing well in school are at an elevated risk of suicidal ideation. Although good school performance is often considered a marker of high intelligence and good general ability, symptoms of major psychiatric disorders and suicidality need to be taken very seriously among adolescents performing well in school.
Assuntos
Escolaridade , Transtornos Psicóticos/psicologia , Suicídio/psicologia , Adolescente , Criança , Feminino , Finlândia/epidemiologia , Humanos , Modelos Logísticos , Masculino , Escalas de Graduação Psiquiátrica , Transtornos Psicóticos/epidemiologia , Instituições Acadêmicas , Fatores Sexuais , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/psicologia , Suicídio/estatística & dados numéricosRESUMO
Schizophrenia is a devastating mental disorder, which is often associated with severe loss of functioning and shortened life expectancy. Suicides and accidents are well-known causes of the excess mortality, but patients with schizophrenia have also been reported to be three times as likely to experience sudden unexpected death as individuals from the general population. This review is aimed to offer an update of the prevalence and mechanisms for sudden cardiac death in schizophrenia. The PubMed database was searched from 1966 up to May 2007 with key words schizophrenia AND " sudden cardiac death" OR "autonomic dysfunction" OR "torsades de pointes". Part of the high death rates may be explained by long-lasting negative health habits, disease- and treatment-related metabolic disorders, and consequent increased frequencies of cardiovascular diseases. The antipsychotic medications may also increase the risk as some antipsychotics may cause prolongation of QT-time, serious ventricular arrhythmias and predispose to sudden death. Autonomic dysfunction seen as low heart rate variability and decreased baroreflex sensitivity may also contribute via malignant arrhythmias. Due to the complex interaction of various risk factors for sudden death, the patients need a comprehensive follow-up of their physical health. In addition, more studies on the role and prevalence of autonomic dysfunction in psychotic patients are needed.
Assuntos
Morte Súbita Cardíaca/etiologia , Esquizofrenia/complicações , Antipsicóticos/efeitos adversos , Arritmias Cardíacas/induzido quimicamente , Dieta/efeitos adversos , Humanos , Estilo de Vida , Síndrome do QT Longo/induzido quimicamente , Obesidade/complicações , Fatores de Risco , Esquizofrenia/tratamento farmacológico , Fumar/efeitos adversosRESUMO
Studies show evidence of longitudinal brain volume decreases in schizophrenia. We studied brain volume changes and their relation to symptom severity, level of function, cognition, and antipsychotic medication in participants with schizophrenia and control participants from a general population based birth cohort sample in a relatively long follow-up period of almost a decade. All members of the Northern Finland Birth Cohort 1966 with any psychotic disorder and a random sample not having psychosis were invited for a MRI brain scan, and clinical and cognitive assessment during 1999-2001 at the age of 33-35 years. A follow-up was conducted 9 years later during 2008-2010. Brain scans at both time points were obtained from 33 participants with schizophrenia and 71 control participants. Regression models were used to examine whether brain volume changes predicted clinical and cognitive changes over time, and whether antipsychotic medication predicted brain volume changes. The mean annual whole brain volume reduction was 0.69% in schizophrenia, and 0.49% in controls (pâ=â0.003, adjusted for gender, educational level, alcohol use and weight gain). The brain volume reduction in schizophrenia patients was found especially in the temporal lobe and periventricular area. Symptom severity, functioning level, and decline in cognition were not associated with brain volume reduction in schizophrenia. The amount of antipsychotic medication (dose years of equivalent to 100 mg daily chlorpromazine) over the follow-up period predicted brain volume loss (pâ=â0.003 adjusted for symptom level, alcohol use and weight gain). In this population based sample, brain volume reduction continues in schizophrenia patients after the onset of illness, and antipsychotic medications may contribute to these reductions.
Assuntos
Antipsicóticos/farmacologia , Encéfalo/efeitos dos fármacos , Encéfalo/patologia , Cognição/efeitos dos fármacos , Esquizofrenia/patologia , Esquizofrenia/fisiopatologia , Adulto , Antipsicóticos/uso terapêutico , Encéfalo/fisiopatologia , Feminino , Humanos , Estudos Longitudinais , Imageamento por Ressonância Magnética , Masculino , Tamanho do Órgão/efeitos dos fármacos , Prognóstico , Esquizofrenia/diagnóstico , Esquizofrenia/tratamento farmacológicoRESUMO
INTRODUCTION: Advanced paternal age (APA) is a reported risk factor for schizophrenia in the offspring. We performed a meta-analysis of this association, considering the effect of gender and study design. METHODS: We identified articles by searching Pub Med, PsychInfo, ISI, and EMBASE, and the reference lists of identified studies. Previously unpublished data from the Northern Finland 1966 Birth Cohort (NFBC 1966) study were also included. RESULTS: There were 6 cohort studies and 6 case-control studies that met the inclusion criteria. In both study designs, there was a significant increase in risk of schizophrenia in the offspring of older fathers (≥30) compared to a reference paternal age of 25-29, with no gender differences. The relative risk (RR) in the oldest fathers (≥50) was 1.66 [95% confidence interval (95% CI): 1.46-1.89, P < 0.01]. A significant increase in risk was also found for younger fathers (<25) in males (RR = 1.08, 95% CI: 1.02-1.14, P = 0.01) but not females (RR = 1.04, 95% CI: 0.97-1.14, P = 0.28). The population attributable risk percentage (PAR%) was 10% for paternal age ≥30 and 5% for paternal age <25. DISCUSSION: Both APA (≥30) and younger paternal age (<25) increase the risk of schizophrenia; younger paternal age may be associated with an increased risk in males but not females. This risk factor increases the risk of schizophrenia as much as any single candidate gene of risk. The mechanism of these associations is not known and may differ for older and younger fathers.
Assuntos
Idade Paterna , Esquizofrenia/epidemiologia , Esquizofrenia/etiologia , Adulto , Fatores Etários , Estudos de Casos e Controles , Estudos de Coortes , Bases de Dados Bibliográficas , Feminino , Finlândia/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Risco , Fatores Sexuais , Adulto JovemRESUMO
OBJECTIVE: To investigate the relationship between adolescent regular daily smoking and later suicides in a prospective longitudinal birth cohort setting. METHOD: Data from the Northern Finland 1966 Birth Cohort Study (N = 10,934) were linked with national death certificates from Statistics Finland. The information on suicide attempts until the end of 2001 was gathered from the Finnish Hospital Discharge Register (FHDR). The information on adolescent regular daily smoking was gathered via a questionnaire in 1980 and 1981, when the subjects were age 14 years. RESULTS: Of all cohort males who smoked regularly at age 14 years, 2.6% committed suicide by age 34 years, while the corresponding proportion was 0.8% among experimental smokers and 0.4% among non-smokers (chi2 = 15.8, df = 2, p < .001). After adjusting for sociodemographic factors in adolescence and psychiatric morbidity, regular smokers were at a 4.05-fold hazard (95% CI = 1.18 to 13.93, p = .026) for committing suicide at a younger age. Corresponding associations were not found among females. The choice of suicide method was not associated with smoking habits in adolescence. Furthermore, the proportion of suicide attempts was significantly higher among regular daily smokers, among both boys (3.3% vs. 1.2%) and girls (4.2% vs. 1.2%), compared with other adolescents. CONCLUSION: At the epidemiologic level, adolescent regular smoking was found to be associated with increased risk for suicide among males before the age of 34 years. Further studies are needed to investigate the effects of smoking on neurobiology of depression, self-damaging aggression, and impulsive behavior.
Assuntos
Comportamento do Adolescente , Fumar/efeitos adversos , Suicídio/estatística & dados numéricos , Adolescente , Estudos de Coortes , Depressão , Feminino , Finlândia/epidemiologia , Humanos , Masculino , Fatores de RiscoRESUMO
This paper updates single risk factors identified by the Northern Finland 1966 Birth Cohort Study up to the end of year 2001 or age 34. Impaired performance (e.g., delayed motor or intellectual development) or adverse exposures (e.g., pregnancy and birth complications, central nervous system diseases) are associated with an increased risk for schizophrenia. However, upper social class girls and clever schoolboys also have an increased risk to develop schizophrenia, contrasted to their peers. Individuals who subsequently develop schizophrenia follow a developmental trajectory that partly and subtly differs from that of the general population; this trajectory lacks flexibility and responsiveness compared to control subjects, at least in the early stages. We propose a descriptive, lifespan, multilevel systems model on the development and course of schizophrenia.